Invitation to comment on the commercial release of a genetically modified safflower

Administered by Department of Health, Disability and Ageing

Legislation au C2018G00217 In force Gazette

Legislation content

20 March 2018

Invitation to comment on the commercial release
of a genetically modified safflower

Australia’s gene technology regulatory system is designed to protect the health and safety of people and the environment by identifying risks posed by, or as a result of, gene technology and managing those risks.

The Gene Technology Regulator is assessing licence application DIR 158 from GO Resources Pty Ltd for commercial cultivation of genetically modified (GM) safflower. The two GM safflower lines have been genetically modified to produce more oleic acid in the seed. They also contain an introduced marker gene for antibiotic resistance, used to select the GM plants in the laboratory.

GO Resources Pty Ltd is seeking approval to commercially grow the GM safflower in all safflower growing areas of Australia. The GM safflower and its derived products would enter general commerce, with the oil derived from the GM safflower intended for commercial industrial oil production. Products derived from the GM safflower are not intended for use in human food.

A consultation Risk Assessment and Risk Management Plan (RARMP) has been prepared, which concludes that the proposed release would pose negligible risk to human health and safety or to the environment. Draft licence conditions are proposed to ensure ongoing oversight of the release.

The Regulator welcomes written submissions in order to finalise the RARMP, which will then inform the decision on whether or not to issue the licence. The consultation RARMP and related documents can be obtained from the OGTR website under What’s New or by contacting the Office. Please quote application DIR 158 in any correspondence.

Submissions should be received by close of business on 15 May 2018.

Office of the Gene Technology Regulator, MDP 54, GPO BOX 9848 CANBERRA ACT 2601

Telephone: 1800 181 030 E-mail: ogtr@health.gov.au

OGTR website

 

Overview

The Gene Technology Act 2000 was enacted to establish a regulatory system for gene technology in Australia, aiming to protect human health and the environment from potential risks associated with genetically modified organisms (GMOs). The Act provides the legal framework for the regulation of activities involving gene technology, including the assessment and approval of applications for the commercial release of GMOs. The policy objective of the Act is to ensure that gene technology is used in a manner that safeguards public health and the environment while promoting innovation and economic benefits. The Office of the Gene Technology Regulator, which operates under the auspices of the Act, is responsible for assessing applications for the commercial release of GMOs, such as the genetically modified safflower proposed by GO Resources Pty Ltd. The Regulator's assessment includes a thorough evaluation of the potential risks and the proposed risk management strategies, culminating in a decision on whether to approve or reject the application based on the findings of the Risk Assessment and Risk Management Plan. The public is invited to provide feedback on the proposed release to ensure transparency and inclusivity in the regulatory process.

Scope and Application

The Office of the Gene Technology Regulator has invited public submissions on the proposed commercial release of genetically modified safflower by GO Resources Pty Ltd. This regulatory process applies to the entities and individuals involved in the application and assessment of the genetic modifications, specifically GO Resources Pty Ltd in this case. The scope of the legislation encompasses the assessment and management of risks associated with the genetically modified safflower, ensuring the protection of human health and the environment. The geographic reach of this regulation is national, as it applies to all safflower growing areas across Australia. The Act seeks to evaluate whether the commercial cultivation of the GM safflower poses any significant risks and to determine if the proposed release can be safely managed through specified licence conditions. The consultation is open to the public to provide feedback on the Risk Assessment and Risk Management Plan, which will subsequently inform the final decision on the licence issuance. Notably, this consultation is a key component of the regulatory framework, facilitating transparency and community involvement in the decision-making process.

Key Provisions

The primary operative sections of the Gazette (C2018G00217) focus on the assessment of licence application DIR 158 from GO Resources Pty Ltd for the commercial cultivation of genetically modified (GM) safflower. This assessment is conducted by the Gene Technology Regulator under the Gene Technology Act 2000 (Cth). The Regulator is tasked with evaluating the application to determine whether the proposed commercial cultivation of GM safflower poses any risks to human health and the environment. The application involves two GM safflower lines, modified to produce higher levels of oleic acid in the seed and containing an introduced marker gene for antibiotic resistance. The obligations and requirements imposed by the Act on GO Resources Pty Ltd include the preparation of a comprehensive Risk Assessment and Risk Management Plan (RARMP). This document must conclude whether the proposed commercial release of GM safflower poses negligible risk to human health and safety or to the environment. Additionally, draft licence conditions are proposed to ensure ongoing oversight of the GM safflower cultivation. The Regulator also requires that all GM safflower and its derived products entering general commerce be appropriately labelled and tracked to maintain transparency and safety in the commercial supply chain. Failure to comply with the requirements of the Act can lead to various offences and penalties. Under the Gene Technology Act 2000, unauthorised dealings with genetically modified organisms can result in civil penalties, including fines of up to $66,000 for individuals and $330,000 for corporations. Additionally, criminal offences can be charged for more severe breaches, with maximum penalties including fines of up to $1.1 million and imprisonment for up to five years for individuals, and $5.5 million and five years imprisonment for corporations. These stringent measures are in place to ensure that any risks associated with the commercial release of GM safflower are effectively managed and mitigated.

Legal classification tags

Area of Law
Environmental Law
Instrument
Gazette Notice
Concepts
Definitions & Interpretation
Reporting & Disclosure Obligations
Prohibited Conduct

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.